Jeanne Wishengrad, MSc

Research Data Analyst III

Research Interests

  • Disparities in cancer screening
  • Health care services in the community setting
  • The role of numeracy and literacy in understanding risk

Jeanne Wishengrad is a Research Data Analyst III at CIPHR.  She holds an MSc in Epidemiology from the University of Toronto.  She has a background in the analysis of large claims databases, including Medicare, Dept. of Defense Health Care System (TRIcare), and others. Prior to her work at CIPHR she worked at the Institute on Disability at the University of New Hampshire where she analyzed the provision of health care services to people with intellectual and developmental disabilities using the New Hampshire All Payor Claims Database.

Jeanne has also worked at Boston Medical Center where she focused on risk adjustment modelling using claims data.  She was part of the federally funded ResDAC team (Research Data Assistance Center) with which she planned, produced and instructed workshops on the use of Medicare data and statistical methodology.  She also consulted for the Health Care Financing Administration’s (now CMS) Office of Strategic Planning on the production of their annual Statistical Supplement. Jeanne has worked with data from the US Renal Data System, the National Breast Screening Study (Canada), and the Medical Expenditure Panel Survey.

In working for a private consulting firm Jeanne designed and implemented a multinational clinical trial pilot of a hypertension medication and collaborated in building cost-effectiveness models for hypertensive medications.

Phillips, KG, Wishengrad, JS & Houtenville, A. Ambulatory Care Sensitive Conditions among All-Payer Claimants with Intellectual and Developmental Disabilities. AJIDD, 2021; 126: 203-215.

Phillips, KG, England, E & Wishengrad JS. Disability-competence training influences health care providers’ conceptualizations of disability: An Evaluation Study. Disabil Health J, 2021; 14: 101-124

Knapp PE, Showers KM, Phipps JC, Speckman JL, Sternthal E, Freund KM, Ash AS, Apovian CM. Self-monitoring of blood glucose with finger tip versus alternative site sampling: Effect on glycemic control in insulin-using patients with type 2 diabetes. Diabetes Technology & Therapeutics, 2009; 11: 219-225.

Speckman JL, Byrne MM, Gerson J, Sugarman J. Determining the costs of institutional review boards. IRB: Ethics & Human Research, 2007; 29: 7-13.

Aggarwal A, Speckman JL, Paasche-Orlow M, Roloff KS, Battaglia TA. The role of numeracy on breast and colorectal cancer screening among urban women. American Journal of Health Behavior, 2007; 31: 557-568.

Sherman B, Gilland G, Speckman JL, Freund KM. The effect of a primary care exercise intervention for rural women.  Preventive Medicine, 2007; 44: 198-201.

Sugarman J, Getz K, Byrne M, Speckman JL, Bowen A, Gerson J. The cost of institutional review boards in academic medical centers. The New England Journal of Medicine, 2005; 352: 1825-1827.

Ash AS, Posner MA, Speckman JL, Franco S, Yacht AC, Bramwell L. Using claims data to examine mortality trends following hospitalization for heart attack in Medicare. Health Services Research, 2003; 38: 1253-1262.

Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: Comparative evaluation of measures of time-in-therapeutic range.  Journal of Thrombosis and Thrombolysis, 2003; 15: 213-216.

Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choices on persistence with antihypertensive therapy: The importance of actual practice data.  Can Med Assoc J, 1999; 160: 41-46.